138-147, Strka, Luboslav, et al
Weekly injections instead of daily
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in noninsulin-dependent diabetes mellitus: A population-based study
Considering the evidence, it is no wonder that the Food and Drug Administration (FDA) has approved Ozempic for lowering the cardiovascular event rate in patients with Type 2 diabetes and cardiovascular disease, such as heart disease
To mitigate these concerns, we included several proxy indicators in our propensity score matching, such as socioeconomic determinants (captured through ICD codes related to employment status, housing circumstances, and social environment), lifestyle counseling codes, and medication profiles that often correlate with health behaviors
Batg P, Barczyski B, Ruszaa M, Paluszkiewicz P